Jeff Karrasch

1.1k total citations
7 papers, 593 citations indexed

About

Jeff Karrasch is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jeff Karrasch has authored 7 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jeff Karrasch's work include Diabetes Treatment and Management (2 papers), vaccines and immunoinformatics approaches (1 paper) and Influenza Virus Research Studies (1 paper). Jeff Karrasch is often cited by papers focused on Diabetes Treatment and Management (2 papers), vaccines and immunoinformatics approaches (1 paper) and Influenza Virus Research Studies (1 paper). Jeff Karrasch collaborates with scholars based in Australia, New Zealand and Greece. Jeff Karrasch's co-authors include Stephen Hall, Stephen Coleman, David Gilpin, Nigel Jones, Dieter Volc, J. Haan, Jacques Montplaisir, David J. Holland, Jim Reid and Françoise Weber and has published in prestigious journals such as Diabetes Care, The Journal of Infectious Diseases and American Heart Journal.

In The Last Decade

Jeff Karrasch

5 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Karrasch Australia	5	343	220	179	111	77	7	593
G.M. Kavanagh United Kingdom	13	140 0.4×	116 0.5×	65 0.4×	102 0.9×	190 2.5×	34	488
David K. Scales United States	8	65 0.2×	180 0.8×	50 0.3×	28 0.3×	4 0.1×	18	861
Lik Thai Lim United Kingdom	14	80 0.2×	20 0.1×	51 0.3×	18 0.2×	24 0.3×	64	519
J. L. Kalliomäki Finland	13	99 0.3×	168 0.8×	69 0.4×	64 0.6×	13 0.2×	63	503
P Vinceneux France	11	160 0.5×	72 0.3×	157 0.9×	34 0.3×	16 0.2×	62	444
Hugo Y. Hsu United States	16	118 0.3×	22 0.1×	90 0.5×	9 0.1×	10 0.1×	36	714
J.M. Mussini France	10	215 0.6×	132 0.6×	52 0.3×	50 0.5×	31 0.4×	16	528
Özlem Evren Kemer Türkiye	14	76 0.2×	36 0.2×	20 0.1×	8 0.1×	73 0.9×	53	644
David Fitzpatrick United States	11	70 0.2×	113 0.5×	207 1.2×	13 0.1×	11 0.1×	23	494
Chi K Yeung Hong Kong	20	112 0.3×	62 0.3×	180 1.0×	27 0.2×	887 11.5×	32	1.1k

Countries citing papers authored by Jeff Karrasch

Since Specialization

Citations

This map shows the geographic impact of Jeff Karrasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Karrasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Karrasch more than expected).

Fields of papers citing papers by Jeff Karrasch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Karrasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Karrasch. The network helps show where Jeff Karrasch may publish in the future.

Co-authorship network of co-authors of Jeff Karrasch

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Karrasch. A scholar is included among the top collaborators of Jeff Karrasch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Karrasch. Jeff Karrasch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gilpin, David, et al.. (2010). Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's Disease. The Journal Of Hand Surgery. 35(12). 2027–2038.e1. 237 indexed citations

2.

Holland, David J., Robert Booy, Ferdinandus de Looze, et al.. (2008). Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial. The Journal of Infectious Diseases. 198(5). 650–658. 207 indexed citations

3.

Montplaisir, Jacques, Jeff Karrasch, J. Haan, & Dieter Volc. (2006). Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial. Movement Disorders. 21(10). 1627–1635. 77 indexed citations

4.

Phillips, Patrick, et al.. (2003). Acarbose Improves Glycemic Control in Overweight Type 2 Diabetic Patients Insufficiently Treated With Metformin. Diabetes Care. 26(2). 269–273. 65 indexed citations

5.

Tanser, Paul H., et al.. (2000). Candesartan Cilexetil is not Associated with Cough in Patients with Enalapril-induced Cough. Blood Pressure. 9(sup1). 56–56.

6.

Krum, Henry, et al.. (1998). Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure. American Heart Journal. 135(2). 237–241. 5 indexed citations

7.

Frewin, D. B., Lindsey Wilson, E. F. O'Sullivan, et al.. (1991). Felodipine in combination with a ?-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. European Journal of Clinical Pharmacology. 41(5). 393–396. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact